Multiplexed comparison of rationally-designed AAV CNS capsids in vivo

被引:0
|
作者
Yebra-Pimentel, E. Santidrian [1 ]
Kieper, S. [1 ]
van der Zon, T. [1 ]
Momchev, L. [1 ]
Moreno, F. [1 ]
Bosma, B. [1 ]
Bashir, N. [1 ]
Waaijer, S. [1 ]
Hoornenborg, W. [1 ]
Heidinga, N. [1 ]
Hoogland, T. [1 ]
Pesic, M. [1 ]
Kusuma, A. [1 ]
机构
[1] UniQure Biopharma BV, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P181
引用
收藏
页码:A107 / A107
页数:1
相关论文
共 50 条
  • [21] Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain
    Jennifer A. Sullivan
    Lisa M. Stanek
    Michael J. Lukason
    Jie Bu
    Shayla R. Osmond
    Elizabeth A. Barry
    Catherine R. O’Riordan
    Lamya S. Shihabuddin
    Seng H. Cheng
    Abraham Scaria
    Gene Therapy, 2018, 25 : 205 - 219
  • [22] Comparison of CNS Transduction by Different AAV Capsids in Mouse and Non-Human Primate
    Goulet, Martin
    Aubin, Justin
    Kells, Adrian P.
    Su, Qin
    Yuan, Shipeng
    Ramamoorthi, Kartik
    Kotin, Rob
    McLaughlin, James
    Gao, Guangping
    Sah, Dinah W. Y.
    MOLECULAR THERAPY, 2015, 23 : S37 - S37
  • [23] Generation of rationally-designed nerve growth factor (NGF) variants with receptor specificity
    Carleton, Laura A.
    Chakravarthy, Reka
    van der Sloot, Almer M.
    Mnich, Katarzyna
    Serrano, Luis
    Samali, Afshin
    Gorman, Adrienne M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 700 - 705
  • [24] RH5: rationally-designed malaria vaccine antigen improving efficacyicacy
    Takashima, Eizo
    Tsuboi, Takafumi
    TRENDS IN PARASITOLOGY, 2024, 40 (10) : 870 - 872
  • [25] Identification of Novel AAV Capsids for Enhanced CNS Gene Transfer
    Chen, Daphne
    Watkins, Zachary A.
    Padegimas, Linas
    Zaric, Violeta
    Miller, Timothy J.
    Gray, Steven J.
    MOLECULAR THERAPY, 2018, 26 (05) : 187 - 187
  • [26] Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent
    Pain, A
    Samanta, S
    Dutta, S
    Saxena, AK
    Shanmugavel, M
    Kampasi, H
    Qazi, GN
    Sanyal, U
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (03): : 411 - 418
  • [27] Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors
    Vassilev, AO
    Tibbles, HE
    DuMez, D
    Venkatachalam, TK
    Uckun, FM
    CURRENT DRUG TARGETS, 2006, 7 (03) : 327 - 343
  • [28] Rationally engineered novel AAV capsids for intra-articular gene delivery
    Li, Wenjun
    Feng, Susi Liu
    Herrschaft, Lizette
    Samulski, R. Jude
    Li, Chengwen
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [29] Constructing an Antigenic Cartography of AAV Capsids by Massively Multiplexed Neutralization Assays
    Zinn, Eric M.
    Schmit, Pauline
    Diop, Cheikh
    Fieldsend, Allegra
    Xiao, Ru
    Zabaleta, Nerea
    Vandenberghe, Luk H.
    MOLECULAR THERAPY, 2022, 30 (04) : 430 - 430
  • [30] Overcoming HIV pathways for escape using rationally-designed anti-HIV antibodies
    Diskin, Ron
    Sather, D. Noah
    Marcovecchio, Paola M.
    Lee, Terri
    West, Anthony P., Jr.
    Gao, Han
    Klein, Florian
    Ari-Halper-Stromberg
    Horwitz, Joshua
    Seaman, Michael S.
    Stamatatos, Leonidas
    Nussenzweig, Michel C.
    Bjorkman, Pamela J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 : 49 - 49